RenovoRx (RNXT) Gross Profit (2025 - 2026)
RenovoRx's (RNXT) quarterly Gross Profit came in at $766000.0 in Q2 2026, up 183.7% year-over-year from $270000.0 in Q2 2025, and up 59.92% quarter-over-quarter from $479000.0 in Q1 2026.
Powered by 
Analysis
RenovoRx (RNXT) Gross Profit (2025 - 2026) Analysis & Trends
RenovoRx has disclosed Gross Profit across 2 years of filings, most recently posting $766000.0 for Q2 2026.
- In Q2 2026, Gross Profit rose 183.7% year-over-year to $766000.0; the TTM figure through Jun 2026 stood at $1.7 million (changed N/A YoY), while the FY2025 annual figure was $796000.0, up 1751.16% from the prior year.
- Gross Profit came in at $766000.0 for Q2 2026 at RenovoRx, up from $479000.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $766000.0 in Q2 2026 to a low of $103000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.69 Bn | 175.09 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.23 Bn | 122.02 Bn | 1.96 Bn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn |
| 4 | Stryker | 103.91 Bn | 100.43 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.54 Bn | 63.00 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.96 Bn | 31.51 Bn | 1.68 Bn |
| 8 | Dexcom | 32.02 Bn | 30.07 Bn | 830.00 Mn |
| 9 | Steris | 20.70 Bn | 20.21 Bn | 684.20 Mn |
| 10 | RenovoRx | 84.43 Mn | 84.43 Mn | 766,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 766,000.00 |
| Mar 31, 2026 | 479,000.00 |
| Dec 31, 2025 | 210,000.00 |
| Sep 30, 2025 | 213,000.00 |
| Jun 30, 2025 | 270,000.00 |
| Mar 31, 2025 | 103,000.00 |